Unadjusted | Adjusted (BIC=203.2) | ||||
---|---|---|---|---|---|
OR (95% CI) | p Value | OR (95% CI) | p Value | ||
Clinical/sociodemographic | |||||
Age (years/10) | 0.72 (0.59 to 0.88) | 0.002* | 0.66 (0.51 to 0.85) | 0.002* | |
Gender | |||||
Female | 1.13 (0.62 to 2.05) | 0.69 | |||
Male | 1.00 (reference) | ||||
BMI | 0.92 (0.87 to 0.98) | 0.01* | |||
NYHA | >1 | 0.52 (0.25 to 1.06) | 0.07 | ||
=1 | 1.00 (reference) | ||||
Maximum LVH | 1.01 (0.96 to 1.06) | 0.71 | |||
Comorbidity | Yes | 0.69 (0.37 to 1.27) | 0.23 | ||
ICD | Yes | 1.74 (0.96 to 3.15) | 0.07 | ||
β-Blocker | Yes | 0.46 (0.25 to 0.84) | 0.01* | ||
FHx SCD | Yes | 1.00 (0.48 to 2.08) | 0.99 | ||
Education | Tertiary | 2.22 (1.18 to 4.18) | 0.01* | 2.31 (1.08 to 4.93) | 0.03* |
Not tertiary | 1.00 | ||||
SEIFA | ≥8 | 1.50 (0.84 to 2.70) | 0.17 | ||
<8 | 1.00 (reference) | ||||
Quality of life | |||||
PCSAT | 1.09 (1.05 to 1.13) | <0.001* | 1.05 (1.0 to 1.09) | 0.05* | |
MCSAT | 1.03 (1.00 to 1.06) | 0.02* | |||
Barriers | |||||
Number of barriers | 0.67 (0.56 to 0.81) | <0.001* | 0.71 (0.56 to 0.91) | 0.01* |
*p<0.05.
BIC, Bayesian Information Criterion; BMI, body mass index; FHx SCD, family history of sudden cardiac death; ICD, implantable cardioverter defibrillator; LVH, left ventricular wall hypertrophy; MCSAT, mental component, weighted t-score; NYHA, New York Heart Association functional classification; PCSAT, physical component, weighted t-score; SEIFA, Socio-Economic Indexes for Areas (ranked 1–10, higher score indicates higher socioeconomic status).